The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The association between female hormonal supplementation and molecular types in colorectal cancer.
 
Seung Won Chung
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Gritstone Bio; MedImmune; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Van K. Morris
Consulting or Advisory Role - Clinical Genomics
Travel, Accommodations, Expenses - Array BioPharma
 
David R. Fogelman
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Bryan K. Kee
Stock and Other Ownership Interests - Medtronic
 
Arvind Dasari
Consulting or Advisory Role - Abbvie/Stemcentrx; Ipsen; Lexicon; Novartis; Voluntis
Research Funding - eFFECTOR Therapeutics; Eisai; Novartis
 
Kanwal Pratap Singh Raghav
Honoraria - Bayer; Eisai
Consulting or Advisory Role - Bayer (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Imad Shureiqi
No Relationships to Disclose
 
Zhi-Qin Jiang
No Relationships to Disclose
 
Patricia A. Jensen-Loewe
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Cathy Eng
Honoraria - Bayer; Celgene; Roche; Sirtex Medical
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Advaxis; Forty Seven; Genentech/Roche; Keryx
Travel, Accommodations, Expenses - Bayer; Genentech/Roche; Sirtex Medical
 
David Menter
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Biocartis; EMD Serono; Genentech; Holy Stone Healthcare; Holy Stone Healthcare; Karyopharm Therapeutics; Merck; Navire; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Jennifer S. Davis
No Relationships to Disclose